MF
TNDM icon

Manchester Financial’s Tandem Diabetes Care TNDM Stock Holding History

Manchester Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250
Closed -$22K – 591
2021
Q1 		$22K Sell
250
-121
-33% -$11.2K 0.01% 308
2020
Q4 		$35K Buy
371
+121
+48% +$12.5K 0.02% 195
2020
Q3 		$28K Hold
250
– – 0.02% 196
2020
Q2 		$25K Hold
250
– – 0.02% 205
2020
Q1 		$16K Hold
250
– – 0.01% 241
2019
Q4 		$15K Buy
+250
New +$15.4K 0.01% 305
2019
Q3 		– Sell
-250
Closed -$16K – 397
2019
Q2 		$16K Buy
+250
New +$16.1K 0.01% 276

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Manchester Financial's TNDM Position: Q2 2021 in Review

Manchester Financial sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 250 shares — an estimated $22K sold.

Manchester Financial first reported a position in TNDM in Q2 2019 and held it in 7 quarters. The position peaked at $35K in Q4 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Manchester Financial reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 250 Tandem Diabetes Care shares in Q2 2021, an estimated $22K.
  • Manchester Financial first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's Tandem Diabetes Care position peaked at $35K in Q4 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.